NovoSeven® RT with MixPro™

NovoSeven® RT, Coagulation Factor VIIa (Recombinant), is indicated for:

• Treatment of bleeding episodes and peri-operative management in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets

• Treatment of bleeding episodes and peri-operative management in adults with acquired hemophilia

For full prescribing, dosing and other information, please refer to the prescribing information linked below.

NovoSeven® RT ‐ NovoNordisk

Size:
1000 mcg, 1 mL Syringe with MixPro®
NDC #:
00169-7201-01
Download:
PI
Size:
2000 mcg, 2 mL Syringe with MixPro®
NDC #:
00169-7202-01
Download:
PI
Size:
5000 mcg, 5 mL Syringe with MixPro®
NDC #:
00169-7205-01
Download:
PI
Size:
8000 mcg, 8 mL Syringe with MixPro®
NDC #:
00169-7208-01
Download:
PI